| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/21/2009 | US7521241 Regulated gene expression in plants |
| 04/21/2009 | US7521240 Chromosome-based platforms |
| 04/21/2009 | US7521239 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 04/21/2009 | US7521235 Unique novel Bacillus thuringiensis gene with Lepidopteran activity |
| 04/21/2009 | US7521234 Mammalian immortalized liver cell |
| 04/21/2009 | US7521230 Nucleic acid encoding a Brain Derived Tau Kinase polypeptide and methods of use thereof |
| 04/21/2009 | US7521229 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 04/21/2009 | US7521228 Spider silk protein encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 04/21/2009 | US7521224 Device which utilizes spatially variant voltages to make subsets of cultured cells or lipid vesicles porous; transferring nucleic acids through membranes; RNA interference |
| 04/21/2009 | US7521223 Expression vector comprising nucleotide sequences coding diacylglycerol acyltransferases for use in enhancing omega fatty acids production in yarrowia |
| 04/21/2009 | US7521222 Farnesyl dibenzodiazepinone and processes for its production |
| 04/21/2009 | US7521217 Carbonic anhydrase having increased stability under high temperature conditions |
| 04/21/2009 | US7521216 Nitrilases and methods for making and using them |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521212 Method for producing oligopolysaccharides |
| 04/21/2009 | US7521211 exhibiting improved activity relative to the native insulin-like growth factor 1 and II polypeptide; The fusion component F is selected from the group consisting of a human IgG constant region, Fc domain, and heavy chain; muscle atrophy |
| 04/21/2009 | US7521208 Human cytokine receptor designated as Zcytor14 polypeptide; antiinflammatory agent |
| 04/21/2009 | US7521207 nucleic acid encoding Macaca mulatta (rhesus monkey) Nur77 nuclear receptor (rhNur77); useful for treating or inhibiting inflammatory diseases such as osteoarthritis and various bone, neurological, and prostrate disorders, and cancer; drug screening; biodrug; culturing |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/21/2009 | US7521204 Bacillus host cell |
| 04/21/2009 | US7521199 Cell; a first exogenous nucleic acid molecule which encodes an estrogen receptor; a second exogenous nucleic acid molecule which encodes a chicken ovalbumin upstream promoter-transcription factor; and a reporter associated with a hepatic lipase promoter |
| 04/21/2009 | US7521191 siRNA targeting connexin 43 |
| 04/21/2009 | US7521190 Compositions and methods for genetic analysis of polycystic kidney disease |
| 04/21/2009 | US7521186 PCR compatible nucleic acid sieving matrix |
| 04/21/2009 | US7521183 Method for detecting Chlamydia trachomatis and kit therefor |
| 04/21/2009 | US7521182 Selection system containing non-antibiotic resistance selection marker |
| 04/21/2009 | US7521181 Methods of diagnosing risk of myocardial infarction by detection of polymorphisms in connexin and NADH/NADPH oxidase genes |
| 04/21/2009 | US7521180 Amplifying microsatellites, short DNA motifs occurring as tandem repeats at numerous loci throughout the genome, with primers; determining a size of the DNA amplification; comparing the size of DNA amplification product with a size of product from normal DNA with identical primers |
| 04/21/2009 | US7521177 Contacting the sample with a flavivirus antigen,produced by expressing a transcriptional unit encoding a Japanese encephalitis virus (JEV) signal sequence and an immunogenic flavivirus antigen of a flavivirus; detecting an increase in antigen/antibody complex formation |
| 04/21/2009 | US7521175 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
| 04/21/2009 | US7521063 A polynucleotides comprise an unmethylated CpG motif, as stimulates and enhancing the efficacy of a vaccine |
| 04/21/2009 | US7521058 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 04/21/2009 | US7521053 Angiopoietin-2 specific binding agents |
| 04/21/2009 | US7521051 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer |
| 04/21/2009 | US7521049 Administering fusion proteins, immunoglobulins, and multimeric proteins; pharmacokinetics; age-related macular degeneration and diabetic retinopathy |
| 04/21/2009 | US7521043 Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines |
| 04/21/2009 | US7521024 Marking the biopolymers to be fractionated with magnetic beads of different sizes or materials causes different migration speeds and thus causes different postions of the biolpolymers after migration |
| 04/21/2009 | CA2437062C Electroporation cuvette insert for facilitating membrane-based fusion |
| 04/21/2009 | CA2399378C Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 04/21/2009 | CA2398469C Antibody for detecting mycoplasma pneumoniae |
| 04/21/2009 | CA2389328C A peroxidase genomic gene derived from ipomoea batatas and a promoter thereof |
| 04/21/2009 | CA2378537C Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 04/21/2009 | CA2362518C Heat-inducible promoter |
| 04/21/2009 | CA2341050C Nucleic acid sequence for potentiating the expression of useful gene and method therefor |
| 04/21/2009 | CA2289122C Bak promoter expression system |
| 04/21/2009 | CA2265976C High level expression of proteins |
| 04/21/2009 | CA2260022C Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of a lim-kinase gene |
| 04/21/2009 | CA2231603C Chicken interleukin-15 and uses thereof |
| 04/21/2009 | CA2193641C 66 kda antigen from borrelia |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA2182034C Treatment for juvenile diabetes |
| 04/21/2009 | CA2115927C Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 04/21/2009 | CA1341593C Process for the production of protein products in aspergillus oryzae anda promoter for the use in aspergillis |
| 04/16/2009 | WO2009049284A2 Compositions and methods for improved glycoprotein sialylation |
| 04/16/2009 | WO2009049147A2 Method of tumor screening by detection of tumour marker in low molecular weight nucleic acid from urine |
| 04/16/2009 | WO2009049126A2 Synthetic genes encoding cry1ac |
| 04/16/2009 | WO2009048971A1 System and method for producing synthetic microorganisms capable of translating proteins containing non-standard amino acids |
| 04/16/2009 | WO2009048966A2 Engineered dicotyledonous promoters capable of expressing in monocotyledonous plants |
| 04/16/2009 | WO2009048932A2 Methods to regulate mirna processing by targeting lin-28 |
| 04/16/2009 | WO2009048633A2 Chimeric chikungunya virus and uses thereof |
| 04/16/2009 | WO2009048560A1 Engineered dendritic cells and uses for the treatment of cancer |
| 04/16/2009 | WO2009048488A1 Glucoamylase variants with altered properties |
| 04/16/2009 | WO2009048487A1 Glucoamylase variants |
| 04/16/2009 | WO2009048354A1 Method for overproducing anti-her2/neu oncogene antibodies in plant |
| 04/16/2009 | WO2009048197A1 The vector system for high expression of proteins in mammalian cells |
| 04/16/2009 | WO2009048133A1 Mite antigenic rice |
| 04/16/2009 | WO2009048071A1 Method and nucleic acid for detection of canine nkt cell |
| 04/16/2009 | WO2009048067A1 Genetically engineered blood coagulation factor x having no sugar chain, and method for production thereof |
| 04/16/2009 | WO2009048027A1 Probe for detecting polymorphism in gene involved in immunity, and use thereof |
| 04/16/2009 | WO2009048024A1 Vector for highly amplifying target gene extrachromosomally and use thereof |
| 04/16/2009 | WO2009047992A1 Udp-glucuronyl transferase and polynucleotide encoding the same |
| 04/16/2009 | WO2009047928A1 Method of producing functional dna, transformant and remedy for disease |
| 04/16/2009 | WO2009047526A1 Use of aptamers in proteomics |
| 04/16/2009 | WO2009047525A1 Methods of controlling plant seed and organ size |
| 04/16/2009 | WO2009047498A2 Mutant enzymes |
| 04/16/2009 | WO2009047362A2 Method for opening tight junctions |
| 04/16/2009 | WO2009047360A1 Il-21 antibodies |
| 04/16/2009 | WO2009047356A1 Compositions and methods for use for antibodies against sclerostin |
| 04/16/2009 | WO2009047009A1 Fusion polypeptide comprising s-antigen repeat units |
| 04/16/2009 | WO2009047007A1 Cho-k1 cell line |
| 04/16/2009 | WO2009046984A1 Hiv preventive vaccine based on hiv specific antibodies |
| 04/16/2009 | WO2009046978A1 Protein expression from multiple nucleic acids |
| 04/16/2009 | WO2009046950A1 Device for the transfer of nucleic acids in cells, and method for the production thereof |
| 04/16/2009 | WO2009046541A1 MODULATION OF SIRPα - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR |
| 04/16/2009 | WO2009046535A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 04/16/2009 | WO2009046520A1 A fusion tag comprising an affinity tag and an ef-hand motif containing polypeptide and methods of use thereof |
| 04/16/2009 | WO2009046514A1 Methods for non-invasive collection of skin cells for dna analysis |
| 04/16/2009 | WO2009046483A1 Therapeutic protocol for the treatment or prevention of thrombocytopenia |
| 04/16/2009 | WO2009025888A3 Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety |
| 04/16/2009 | WO2009025470A3 Novel corynebacterium glutamicum promoter |
| 04/16/2009 | WO2009023308A3 Genetically modified babesia parasites expressing protective tick antigens and uses thereof |
| 04/16/2009 | WO2009021000A3 Protein and dna sequence encoding a cold adapted subtilisin-like activity |
| 04/16/2009 | WO2009020346A3 A gastric carcinoma gene znf312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same |
| 04/16/2009 | WO2009020236A3 Baculoviral vectors with a dual vertebrate and baculovirus promoter controlling an immunogenic fusion gene |
| 04/16/2009 | WO2009019007A3 Sdf-1 binding nucleic acids and the use thereof |
| 04/16/2009 | WO2009018667A8 Plant bioreactor for the production of interleukin-24 cytokine |
| 04/16/2009 | WO2009012309A3 Nucleic acid based fluorescent sensor for divalent copper ion detection |
| 04/16/2009 | WO2009012173A3 Enhanced biotherapeutic production using inhibitory rna |
| 04/16/2009 | WO2009012110A3 Unique calibrator polynucleotides and methods of using in quantitative nucleic acid assays |
| 04/16/2009 | WO2008157789A3 Rational design of binding proteins that recognize desired specific squences |